Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(2):81; doi:10.1093/jnci/djj041
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Cost-Effectiveness in ALTS

Findings from the atypical squamous cells of undetermined significance (ASCUS) and low-grade squamous intraepithelial lesions (LSIL) triage study (ALTS) suggest that for women diagnosed with ASCUS, human papillomavirus (HPV) DNA testing, which refers about half of women to colposcopy, is as effective at detecting cervical intraepithelial neoplasia (CIN) 3 or cervical cancer as immediate colposcopy for all women. To investigate whether HPV DNA testing is a cost-effective alternative to immediate colposcopy or conservative management with up to three Pap smears, Kulasingam et al. (p. 92) analyzed data from the ALTS . . . [Full Text of this Article]

HSIL and HIV and HPV Infection in Senegalese Women

Sex Hormones, Breast Cancer Risk, and Tamoxifen Response

Breast Cancer Risk in Icelandic BRCA2 Mutation Carriers

IGF1 Genetic Variation and Prostate Cancer Risk

Diabetes Mellitus and Colorectal Cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?